Introduction: Cervical cancer remains a major cause of morbidity and mortality among the female population in sub-Saharan Africa. Vaccination against human papillomavirus (HPV), the main causative agent, has the potential to eradicate cervical cancer. In-country evidence of sub-types of HPV associated with cervical cancer is scanty, thus necessitating this study. Methods: A cross-sectional study was performed using a multistage sampling technique. A molecular technique using the Cobas 4800 machine was used for genotyping. Results: 570 participants were recruited for the study. The mean age of the participants was 32.4 ± 5.2 years. The age of sexual debut ranged from 15 - 24 years with a median of 19 years. 194 participants were positive for high-risk HPV giving a prevalence of 34%. 3% (n = 17) were positive for HPV, 16. 4% (23) had a positive result for HPV, 18. 27% (n = 154) had a positive result for other high-risk groups (OHR) other than HPV 16 or 18. Positive status for high-risk HPV is associated with the presence of genital warts (OR = 7.5), a Positive HIV status (OR = 3.48), abnormal vaginal discharge (OR = 2.20), multiple sexual partners (OR = 2.30), and obesity (OR = 2.70). The prevalence of HIV in the study population was 6.84% (n = 39). Conclusion: Another High-risk HPV other than 16 and 18 appears to be the predominant form of HPV infection in Nigerian women. The risk of being positive for high-risk HPV is associated with the presence of genital warts, abnormal vaginal discharge, a positive HIV status, multiple sexual partners and Obesity. It is therefore necessary to disaggregate and study these high-risk sub-types.
References
[1]
Agaba, P.A., Thacher, T.D., Ekwempu, C.C. and Idoko, J.A. (2009) Cervical Dysplasia in Nigerian Women Infected with HIV. International Journal of Gynecology & Obstetrics, 107, 99-102. https://doi.org/10.1016/j.ijgo.2009.06.006
[2]
Akarolo-Anthony, S.N., Famooto, A.O., Dareng, E.O., Olaniyan, O.B., Offiong, R., Wheeler, C.M. and Adebamowo, C.A. (2014) Age-Specific Prevalence of Human Papilloma Virus Infection among Nigerian Women. BMC Public Health, 14, Article No. 656. https://doi.org/10.1186/1471-2458-14-656
[3]
Ault, K.A. (2006) Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract. Infectious Diseases in Obstetrics and Gynecology, 2006, Article No. 40470. https://doi.org/10.1155/IDOG/2006/40470
[4]
Averbach, H.S., Gravitt, P.E., Nowak, G.R., Celentano, D.D., Dunbar, S.M., Morrison, S.C., Grimes, B. and Padian, N.S. (2010) The Association between Cervical HPV Infection and HIV Acquisition among Women in Zimbabwe. AIDS, 24, 1035-1042. https://doi.org/10.1097/QAD.0b013e3283377973
[5]
Brotherton, J.M.I. (2018) Human Papillomavirus Vaccination Update: Nonavalent Vaccine and the Two-Dose Schedule. Australian Journal of General Practice, 47, 417-421. https://doi.org/10.31128/AJGP-01-18-4462
[6]
Cage, C.J., Ajenifuja, O.K., Wentzensen, A.N., et al. (2011) The Age-Specific Prevalence of Human Papilloma Virus and Risk of Cytologic Abnormalities in Rural Nigeria: Implications for Screen and Treat Strategies. International Journal of Cancer, 10, 1002-26211.
[7]
Cerdeira, R.C., Sanchez-Blanco, E. and Alba, A. (2012) Evaluation of Association between Vaginal Infections and High-Risk Human Papillomavirus Types in Female Sex Workers in Spain. ISRN Obstetrics and Gynecology, 2012, Article ID: 240190. https://doi.org/10.5402/2012/240190
[8]
Clifford, G.M., Smith, J.S., Plummer, M., Muñoz, N. and Franceschi, S. (2003) Human Papillomavirus Types in Invasive Cervical Cancer Worldwide: A Meta-Analysis. British Journal of Cancer, 88, 63-73. https://doi.org/10.1038/sj.bjc.6600688
[9]
Clifford, G.M., Gallus, S., Herrero, R., Munoz, N., Snijders, P.J., Vaccarella, S., et al. (2005) Worldwide Distribution of Human Papillomavirus Types in Cytologically Normal Women in the International Agency for Research on Cancer HPV Prevalence Surveys: A Pooled Analysis. The Lancet, 366, 991-998. https://doi.org/10.1016/S0140-6736(05)67069-9
[10]
De Sanjosé, S., Almirall, R., Lloveras, B., et al. (2003) Cervical Human Papillomavirus Infection in the Female Population in Barcelona, Spain. Sexually Transmitted Diseases, 30, 788-793. https://doi.org/10.1097/01.OLQ.0000080177.82204.E0
[11]
Ezechi, O.C. (2014) The Battleground of Two Infections and Cancer: Human Papilloma Virus, Premalignant Lesions of the Cervix and Their Interaction with Human Immunodeficiency Virus in Southwestern Nigeria. Dissertation, Lund University, Lund.
[12]
Gage, J.C., Ajenifuja, K.O., Wentzensen, N., et al. (2013) Effectiveness of a Simple Rapid Human Papillomavirus DNA Test in Rural Nigeria. International Journal of Cancer, 131, 2903-2909.
[13]
Herrero, R., Castle, P.E., Schiffman, M., et al. (2005) Epidemiologic Profile of Type-Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica. The Journal of Infectious Diseases, 191, 1796-1807. https://doi.org/10.1086/428850
[14]
Idelot-Rousseau, M.N., Nagot, N., Costes-martineau, V., et al. (2006) Human Papilloma Virus Genotype Distribution and Cervical Squamous Intraepithelial Lesions among High-Risk Women with and without HIV-1 Infection in Burkina Faso. British Journal of Cancer, 95, 355-362. https://doi.org/10.1038/sj.bjc.6603252
[15]
Idso, C. (2009) Sexually Transmitted Infection Prevention in Newly Single Older Women: A Forgotten Health Promotion Need. Journal for Nurse Practitioners, 5, 440-446. https://doi.org/10.1016/j.nurpra.2009.02.015
[16]
Jung, U.S., Choi, J.S., Ko, J.H., et al. (2013) Decreased Prevalence of High-Risk Human Papillomavirus Infection Is Associated with Obesity. European Journal of Gynaecological Oncology, 34, 70-74.
[17]
Kahn, J.A., Rosenthal, S.L., Succop, P.A., Ho, G.Y. and Burk, R.D. (2002) Mediators of the Association between Age of First Sexual Intercourse and Subsequent Human Papillomavirus Infection. Paediatrics, 109, E5. https://doi.org/10.1542/peds.109.1.e5
[18]
Liu, S., Rostich, F.A., Viscidi, P.R., Michelle, I.S., Burke, A.E. and Gravitt, E.P. (2013) Obesity and Human Papillomavirus Infection in Perimenopausal Women. The Journal of Infectious Diseases, 208, 1071-1080. https://doi.org/10.1093/infdis/jit297
[19]
Mette, T., Jensen, S.J., Bech, H.B., Blaaker, J., Svanholm, H. and Andersen, B. (2018) Good Concordance of HPV Detection between Cevico-Vaginal Self Samples and General Practitioner-Collected Samples Using the Cobas 4800 HPV DNA Test. BMC Infectious, 18, Article No. 348.
[20]
Muñoz, N., Bosch, F.X., de Sanjose, S., et al. (2003) Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. The New England Journal of Medicine, 348, 518-527. https://doi.org/10.1056/NEJMoa021641
[21]
National Population Commission (2020) Nigeria Population and Housing Census. http://ghdx.healthdata.org/organizations/national-population-commission-nigeria
[22]
Nejo, Y.T., Olaleye, D.O. and Odaibo, G.N. (2018) Prevalence and Risk Factors for Genital Human Papillomavirus Infections among Women in Southwest Nigeria. Archives of Basic and Applied Medicine, 6, 105-112.
[23]
Nweke, I.G., Banjo, A.A.F., Abdulkareem, F.B. and Nwadike, V.U. (2013) Prevalence of Human Papillomavirus DNA in HIV Positive Women in Lagos University Teaching Hospital (LUTH) Lagos, Nigeria. Microbiology Research Journal International, 3, 400-413. https://doi.org/10.9734/BMRJ/2013/4151
[24]
Okunade, K.S., Nwogu, C.M., Oluwole, A.A. and Anorlu, R.I. (2017) Prevalence and Risk Factors for Genital High-Risk Human Papillomavirus Infection among Women Attending the Out-Patient Clinics of a university Teaching Hospital in Lagos, Nigeria. The Pan African Medical Journal, 28, Article No. 227. https://doi.org/10.11604/pamj.2017.28.227.13979
[25]
Salazar, E.L., Mercadom, E. and Calzada, L. (2005) Human Papillomavirus HPV-16 DNA as an Epitheliotropic Virus That Induces Hyperproliferation in Squamous Penile Tissue. Archives of Andrology, 51, 327-334. https://doi.org/10.1080/014850190923396
[26]
Schnatz, P.F., Markelova, N.V., Holmes, D., Mandavilli, S.R. and O’Sullivan, D.M. (2008) The Prevalence of Cervical HPV and Cytological Abnormalities in Association with Reproductive Factors of Rural Nigerian Women. Journal of Women’s Health (Larchmt), 17, 279-285. https://doi.org/10.1089/jwh.2006.0295
[27]
Ter Meulen, J., Eberhardt, H.C., Luande, J., et al. (1992) Human Papillomavirus (HPV) Infection, HIV Infection and Cervical Cancer in Tanzania, East Africa. International Journal of Cancer, 51, 515-521. https://doi.org/10.1002/ijc.2910510403
[28]
Thomas, J.O., Herrero, R., Omigbodun, A.A., et al. (2004) Prevalence of Papilloma Virus Infection in Women in Ibadan, Nigeria: A Population-Based Study. British Journal of Cancer, 90, 638-645. https://doi.org/10.1038/sj.bjc.6601515
[29]
Trottier, H. and Franco, E.L. (2006) The Epidemiology of Genital Human Papillomavirus Infection. Vaccine, 24, S1-S15. https://doi.org/10.1016/j.vaccine.2005.09.054
[30]
Wall, S.R., Scherf, C.F., Morison, L., et al. (2005) Cervical Human Papillomavirus Infection and Squamous Intraepithelial Lesions in Rural Gambia, West Africa: Viral Sequence Analysis and Epidemiology. British Journal of Cancer, 93, 1068-1076. https://doi.org/10.1038/sj.bjc.6602736
[31]
Walboomers, J.M., Jacobs, M.V., Manos, M.M., et al. (1999) Human Papillomavirus Is a Necessary Cause of Invasive Cervical Cancer Worldwide. The Journal of Pathology, 189, 12-19. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
[32]
Xi, L.F., Toure, P., Critchlow, C.W., et al. (2003) Prevalence of Specific Types of Human Papillomavirus and Cervical Squamous Intraepithelial Lesions in Consecutive, Previously Unscreened, West-African Women over 35 Years of Age. International Journal of Cancer, 103, 803-809. https://doi.org/10.1002/ijc.10876
